ALNY vs ATHA · P/E 76, rev $2.25B vs $26.6M cap
Alnylam Pharmaceuticals Inc (ALNY) versus Athira Pharma Inc (ATHA) — a side-by-side from cached financials, not a winner call.
Alnylam Pharmaceuticals Inc (ALNY) is a biotechnology company listed on US.
Athira Pharma Inc (ATHA) is a biotechnology company listed on US.
Latest reported ALNY revenue for 2024-12-31 was $2.25B. Net income was -$278.2M. Revenue was up 23.0% from 2023-12-31 to 2024-12-31. ALNY currently screens at market cap $40.46B and trailing P/E 76.3.
ATHA does not have a complete income-statement cache yet.
ALNY currently screens at market cap $40.46B and trailing P/E 76.3. ATHA currently screens at market cap $26.6M.
Not investment advice. Open the ALNY and ATHA stock pages for the full models.
Not investment advice.